Jennifer Daniels
Known title: DirectorCIK: 0001410523
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Colgate-Palmolive dividend focus ahead of Q3 earnings call. Recent coverage lists Colgate‑Palmolive as a dividend champion and a contender for income‑focused investors. The company will host its 2026 third‑quarter earnings webcast on October 30, where results and guidance are expected. Investors noting the upcoming November 13 dividend should be aware of the October 20 record date to qualify for the payment. The stock continues to trade with a dividend yield of about 2.5%.
Transaction History
| STZ | ▲ Buy | Option Exercise | 1,114 | $0 | 7/10/2026 | View on chart |
| CL | ▼ Sell | Tax Withholding | 12,351 | $1.2M | 2/23/2026 | View on chart |
| CL | ▲ Buy | Grant | 25,742 | $0 | 2/23/2026 | View on chart |
| CL | ▲ Buy | Option Exercise | 22,000 | $1.6M | 2/4/2026 | View on chart |
| CL | ▼ Sell | Open Market | 22,000 | $2.1M | 2/4/2026 | View on chart |
| CL | ▼ Sell | Tax Withholding | 213 | $17K | 12/3/2025 | View on chart |
| CL | ▼ Sell | Tax Withholding | 900 | $75K | 9/13/2025 | View on chart |
| CL | ▼ Sell | Tax Withholding | 521 | $43K | 9/12/2025 | View on chart |
| CL | ▲ Buy | Grant | 4,592 | $0 | 9/11/2025 | View on chart |
| STZ | ▲ Buy | Option Exercise | 503 | $0 | 7/10/2025 | View on chart |
| CL | ▲ Buy | Grant | 18,601 | $0 | 2/13/2025 | View on chart |
| CL | ▼ Sell | Tax Withholding | 7,829 | $687K | 2/13/2025 | View on chart |
| CL | ▼ Sell | Tax Withholding | 168 | $16K | 12/3/2024 | View on chart |
| CL | ▼ Sell | Tax Withholding | 762 | $81K | 9/13/2024 | View on chart |
| CL | ▲ Buy | Grant | 3,630 | $0 | 9/12/2024 | View on chart |
| CL | ▲ Buy | Option Exercise | 22,000 | $1.6M | 8/8/2024 | View on chart |
| CL | ▼ Sell | Open Market | 22,000 | $2.3M | 8/8/2024 | View on chart |
| STZ | ▲ Buy | Option Exercise | 463 | $0 | 7/10/2024 | View on chart |
| CL | ▲ Buy | Option Exercise | 22,250 | $1.6M | 5/14/2024 | View on chart |
| CL | ▼ Sell | Open Market | 22,250 | $2.1M | 5/14/2024 | View on chart |
| CL | ▼ Sell | Open Market | 3,538 | $300K | 2/20/2024 | View on chart |
| CL | ▼ Sell | Open Market | 5,790 | $486K | 2/16/2024 | View on chart |
| CL | ▲ Buy | Grant | 11,010 | $0 | 2/15/2024 | View on chart |
| CL | ▲ Buy | Option Exercise | 61,633 | $4.2M | 2/1/2024 | View on chart |
| CL | ▼ Sell | Open Market | 61,633 | $5.2M | 2/1/2024 | View on chart |
| CL | ▼ Sell | Tax Withholding | 245 | $19K | 12/6/2023 | View on chart |
| CL | ▲ Buy | Option Exercise | 3,800 | $259K | 11/30/2023 | View on chart |
| CL | ▼ Sell | Open Market | 3,800 | $300K | 11/30/2023 | View on chart |
| CL | ▲ Buy | Grant | 5,301 | $0 | 9/13/2023 | View on chart |
| CL | ▲ Buy | Option Exercise | 24,704 | $1.8M | 9/11/2023 | View on chart |
| CL | ▼ Sell | Open Market | 24,704 | $1.8M | 9/11/2023 | View on chart |
| STZ | ▲ Buy | Option Exercise | 469 | $0 | 7/10/2023 | View on chart |
| CL | ▲ Buy | Option Exercise | 24,703 | $1.8M | 5/19/2023 | View on chart |
| CL | ▼ Sell | Open Market | 24,703 | $2.0M | 5/19/2023 | View on chart |
| CL | ▼ Sell | Open Market | 4,922 | $361K | 2/17/2023 | View on chart |
| CL | ▲ Buy | Grant | 9,361 | $0 | 2/16/2023 | View on chart |
| CL | ▲ Buy | Option Exercise | 24,703 | $1.8M | 8/4/2022 | View on chart |
| CL | ▼ Sell | Open Market | 24,703 | $2.0M | 8/4/2022 | View on chart |
| CL | ▼ Sell | Open Market | 8,812 | $698K | 2/18/2022 | View on chart |
| CL | ▲ Buy | Grant | 16,797 | $0 | 2/17/2022 | View on chart |
| CL | ▲ Buy | Option Exercise | 40,580 | $3.0M | 2/3/2022 | View on chart |
| CL | ▼ Sell | Open Market | 40,580 | $3.4M | 2/3/2022 | View on chart |
| CL | ▼ Sell | Tax Withholding | 337 | $26K | 12/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
STZ eyes M&A as US beer market stalls
Constellation Brands said it is back in the merger‑and‑acquisition market while the U.S. beer segment shows little growth. Jim Cramer noted a recent price reversal that has drawn fresh analyst attention. Comparisons with fellow brewer TAP focus on potential retirement‑income benefits, highlighting investor interest in the stock.
STZ eyes M&A as US beer market stalls. Constellation Brands said it is back in the merger‑and‑acquisition market while the U.S. beer segment shows little growth. Jim Cramer noted a recent price reversal that has drawn fresh analyst attention. Comparisons with fellow brewer TAP focus on potential retirement‑income benefits, highlighting investor interest in the stock.